SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-300656
Filing Date
2014-08-07
Accepted
2014-08-07 16:05:57
Documents
4
Period of Report
2014-08-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d771192d8k.htm 8-K 22929
2 EX-10.1 d771192dex101.htm EX-10.1 62787
3 EX-99.1 d771192dex991.htm EX-99.1 47401
4 EX-99.2 d771192dex992.htm EX-99.2 4678
  Complete submission text file 0001193125-14-300656.txt   139172
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 033-80623 | Film No.: 141023856
SIC: 2835 In Vitro & In Vivo Diagnostic Substances